Evidence Desk Prompt: Does selenium supplementation reduce levothyroxine dose requirements in Hashimoto's?
Clinical question for the community: We're seeing anecdotal reports of Hashimoto's patients requiring 12.5-25mcg levothyroxine dose reductions after 12-16 weeks of selenium 200mcg daily supplementation. Proposed mechanism: selenium (as selenomethionine or selenocysteine) is a cofactor for glutathione peroxidase and iodothyronine deiodinases, potentially improving T4→T3 conversion efficiency and reducing autoimmune thyroid inflammation (lower TPO/TG antibodies). Has anyone experienced this? Did your endocrinologist reduce your dose after adding selenium? What were your before/after TSH, free T4, and TPO antibody levels?
NIH ODS and multiple European Thyroid Journal RCTs show selenium 200mcg daily reduces TPO antibodies by 20-40% in Hashimoto's patients over 6-12 months. Some studies report modest TSH reduction (0.3-0.8 mIU/L), suggesting improved peripheral T4→T3 conversion, but dose reduction protocols are not standardized in clinical guidelines.